New Delhi [India], November 25 (ANI): A day after Serum Institute of India (SII) Chief Executive Officer Adar Poonawalla asserted that its "soon to be widely available COVID-19 vaccine will offer protection up to 90 per cent in one type of dosage regime", Council of Scientific and Industrial
New Delhi [India], November 23 (ANI): Serum Institute of India (SII), CEO, Adar Poonawalla on Monday said that he is delighted to hear that Covidshield, soon to be widely available COVID-19 vaccine, will offer protection up to 90 per cent in one dosage regime and 62 per cent in another.
New Delhi [India], September 29 (ANI): Following a tweet by the Serum Institute of India, the Union Health Ministry on Tuesday said it disagrees with the mathematics which asked the government whether it has Rs 80,000 crore to buy and distribute COVID-19 vaccine to everyone in India.
Bhubaneswar (Odisha) [India], July 22 (ANI): Odisha Chief Minister Naveen Patnaik on Wednesday spoke to Adar Poonawalla, CEO of Serum Institute over a video call to discuss on the progress of coronavirus vaccine.
New Delhi [India], June 13 (ANI): Adar Poonawalla, CEO and Owner, Serum Institute of India (SII) on Saturday announced that his firm has signed a deal with Astra Zeneca to supply one billion doses of vaccine for low and middle-income countries before the end of 2020 to combat coronavirus.
Pune (Maharashtra) [India] Dec 12 (ANI/BusinessWire India): Poonawalla Finance Private Limited, a fastest-growing Non-Banking Finance Company (NBFC), headquartered in Pune, has achieved a major milestone by crossing INR 1000 Crore AUM in November 2019; within eight months from its inception.
New Delhi [India], Feb 12 (ANI): Svasti Microfinance Private Limited (Svasti) has raised a total of Rs. 34 Crores capital from Nordic Microfinance Initiative (NMI), Serum Institute of India CEO Adar Poonawalla, and other investors.